Skip to main content

Hepatobiliary and Pancreatic Interventions

  • Chapter
Demystifying Interventional Radiology

Abstract

This chapter covers the most common hepatobiliary interventions encountered in interventional radiology. Image-guided biopsy of the liver is undertaken to obtain a tissue sample for pathological diagnosis of a lesion initially identified on imaging.

Percutaneous cholecystostomy decompresses the gallbladder under fluoroscopic guidance and/or ultrasound guidance. This reduces symptoms and inflammation from acute cholecystitis. It is most useful in high-risk patients as a bridging therapy to cholecystectomy.

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and sixth most common malignancy worldwide. The premise of transarterial chemoembolization (TACE) is to induce ischemia of the tumor bed and increase susceptibility or response to chemotherapeutic agents, such as sorafenib. TACE can be used to treat patients who do not meet criteria for resection and to serve as a bridge therapy until transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Krokidis M, Orgera G, Rossi M, et al. Interventional radiology in the management of benign biliary stenoses, biliary leaks and fistulas: a pictorial review. Insights Imaging. 2013;4(1):77–84.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Little MW, Briggs JH, Tapping CR, et al. Percutaneous cholecystostomy: the radiologist's role in treating acute cholecystitis. Clin Radiol. 2013;68(7):654–60.

    Article  CAS  PubMed  Google Scholar 

  3. Thompson Coon J, Rogers G, Hewson P, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess. 2007;11(34):1–206.

    Article  CAS  PubMed  Google Scholar 

  4. Singal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev. 2012;21(5):793–9.

    Article  PubMed  Google Scholar 

  5. Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Vauthey JN, Dixon E, Abdalla EK, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12(5):289–99.

    Google Scholar 

  7. Kadri HS, Blank S, Wang Q, et al. Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis B and minimally fibrotic liver. Eur J Surg Oncol. 2013;39(12):1371–6.

    Article  CAS  PubMed  Google Scholar 

  8. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  9. Kennedy SA, Gopee-Ramanan P, Dath D. Hepatocellular carcinoma: a clinical review. MUMJ. 2014;11(1):9–14.

    Google Scholar 

  10. Tang A, Cruite I, Sirlin CB. Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI. Expert Rev Gastroenterol Hepatol. 2013;7(3):269–79.

    Article  CAS  PubMed  Google Scholar 

  11. Steward MJ, Warbey VS, Malhotra A, et al. Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics. 2008;28(4):1131–45.

    Article  PubMed  Google Scholar 

  12. Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31(4):426–32.

    Article  PubMed  Google Scholar 

  13. Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol. 2013;30(1):3–11.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Raoul JL, Sangro B, Forner A, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev. 2011;37(3):212–20.

    Article  PubMed  Google Scholar 

  15. Bester L, Meteling B, Boshell D, et al. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature. J Med Imaging Radiat Oncol. 2014;58(3):341–52.

    Article  PubMed  Google Scholar 

  16. Salem R, Lewandowski R, Atassi B. Treatment of unresectable hepatocellular carcinoma with use of Y90 microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16:1627–39.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Prasaanthan Gopee-Ramanan HBSc (HD), HBSc (MRS), MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gopee-Ramanan, P. (2016). Hepatobiliary and Pancreatic Interventions. In: Athreya, S. (eds) Demystifying Interventional Radiology. Springer, Cham. https://doi.org/10.1007/978-3-319-17238-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17238-5_13

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17237-8

  • Online ISBN: 978-3-319-17238-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics